153 related articles for article (PubMed ID: 37967611)
1. Pulmonary hypertension in sickle cell disease.
Al Kahf S; Roche A; Baron A; Chantalat-Auger C; Savale L
Presse Med; 2023 Dec; 52(4):104209. PubMed ID: 37967611
[TBL] [Abstract][Full Text] [Related]
2. An official American Thoracic Society clinical practice guideline: diagnosis, risk stratification, and management of pulmonary hypertension of sickle cell disease.
Klings ES; Machado RF; Barst RJ; Morris CR; Mubarak KK; Gordeuk VR; Kato GJ; Ataga KI; Gibbs JS; Castro O; Rosenzweig EB; Sood N; Hsu L; Wilson KC; Telen MJ; Decastro LM; Krishnamurti L; Steinberg MH; Badesch DB; Gladwin MT;
Am J Respir Crit Care Med; 2014 Mar; 189(6):727-40. PubMed ID: 24628312
[TBL] [Abstract][Full Text] [Related]
3. Pathways to pulmonary hypertension in sickle cell disease: the search for prevention and early intervention.
Shilo NR; Morris CR
Expert Rev Hematol; 2017 Oct; 10(10):875-890. PubMed ID: 28817980
[TBL] [Abstract][Full Text] [Related]
4. Pathophysiology and treatment of pulmonary hypertension in sickle cell disease.
Gordeuk VR; Castro OL; Machado RF
Blood; 2016 Feb; 127(7):820-8. PubMed ID: 26758918
[TBL] [Abstract][Full Text] [Related]
5. Serum apelin as a novel non-invasive marker for subclinical cardiopulmonary complications in children and adolescents with sickle cell disease.
Elbarbary NS; Ismail EA; Roushdy A; Fahmy E
Blood Cells Mol Dis; 2016 Mar; 57():1-7. PubMed ID: 26852648
[TBL] [Abstract][Full Text] [Related]
6. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.
Yawn BP; Buchanan GR; Afenyi-Annan AN; Ballas SK; Hassell KL; James AH; Jordan L; Lanzkron SM; Lottenberg R; Savage WJ; Tanabe PJ; Ware RE; Murad MH; Goldsmith JC; Ortiz E; Fulwood R; Horton A; John-Sowah J
JAMA; 2014 Sep; 312(10):1033-48. PubMed ID: 25203083
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary artery occlusion pressure may overdiagnose pulmonary artery hypertension in sickle cell disease.
Sharma S; Efird J; Kadali R; Mehra S; Chohan H; Daggubati R; Liles D; Gouge C; Boettger P; Knupp C
Clin Cardiol; 2013 Sep; 36(9):524-30. PubMed ID: 23893714
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary hypertension in sickle cell disease.
Lee MT; Rosenzweig EB; Cairo MS
Clin Adv Hematol Oncol; 2007 Aug; 5(8):645-53, 585. PubMed ID: 17982405
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary arterial hypertension.
Montani D; Günther S; Dorfmüller P; Perros F; Girerd B; Garcia G; Jaïs X; Savale L; Artaud-Macari E; Price LC; Humbert M; Simonneau G; Sitbon O
Orphanet J Rare Dis; 2013 Jul; 8():97. PubMed ID: 23829793
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary hypertension in sickle cell disease: diagnosis and management.
Ataga KI; Klings ES
Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):425-31. PubMed ID: 25696889
[TBL] [Abstract][Full Text] [Related]
11. Review: Hemodynamic Characteristics and Outcomes of Sickle Cell Disease Associated Pulmonary Hypertension.
Mehari A; Thomas AV; Thomas AN; Johnson MS
Ethn Dis; 2016 Oct; 26(4):545-552. PubMed ID: 27773982
[TBL] [Abstract][Full Text] [Related]
12. Sickle cell anemia-associated pulmonary arterial hypertension.
Machado RF
J Bras Pneumol; 2007; 33(5):583-91. PubMed ID: 18026658
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary hypertension diagnosed by right heart catheterisation in sickle cell disease.
Fonseca GH; Souza R; Salemi VM; Jardim CV; Gualandro SF
Eur Respir J; 2012 Jan; 39(1):112-8. PubMed ID: 21778170
[TBL] [Abstract][Full Text] [Related]
14. [Pulmonary complications of sickle cell disease in children].
Pincez T; Calamy L; Germont Z; Lemoine A; Lopes AA; Massiot A; Tencer J; Thivent C; Hadchouel A
Arch Pediatr; 2016 Oct; 23(10):1094-1106. PubMed ID: 27642150
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary hypertension in patients with sickle cell/beta thalassemia: incidence and correlation with serum N-terminal pro-brain natriuretic peptide concentrations.
Voskaridou E; Tsetsos G; Tsoutsias A; Spyropoulou E; Christoulas D; Terpos E
Haematologica; 2007 Jun; 92(6):738-43. PubMed ID: 17550845
[TBL] [Abstract][Full Text] [Related]
16. The different facets of sickle cell disease-related pulmonary hypertension.
Prohaska CC; Machado RF
Curr Opin Pulm Med; 2021 Sep; 27(5):319-328. PubMed ID: 34224433
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary arterial hypertension and left-sided heart disease in sickle cell disease: clinical characteristics and association with soluble adhesion molecule expression.
Klings ES; Anton Bland D; Rosenman D; Princeton S; Odhiambo A; Li G; Bernard SA; Steinberg MH; Farber HW
Am J Hematol; 2008 Jul; 83(7):547-53. PubMed ID: 18383329
[TBL] [Abstract][Full Text] [Related]
18. Hemodynamic predictors of mortality in adults with sickle cell disease.
Mehari A; Alam S; Tian X; Cuttica MJ; Barnett CF; Miles G; Xu D; Seamon C; Adams-Graves P; Castro OL; Minniti CP; Sachdev V; Taylor JG; Kato GJ; Machado RF
Am J Respir Crit Care Med; 2013 Apr; 187(8):840-7. PubMed ID: 23348978
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease.
Gladwin MT; Sachdev V; Jison ML; Shizukuda Y; Plehn JF; Minter K; Brown B; Coles WA; Nichols JS; Ernst I; Hunter LA; Blackwelder WC; Schechter AN; Rodgers GP; Castro O; Ognibene FP
N Engl J Med; 2004 Feb; 350(9):886-95. PubMed ID: 14985486
[TBL] [Abstract][Full Text] [Related]
20. Circulating platelet and erythrocyte microparticles in young children and adolescents with sickle cell disease: Relation to cardiovascular complications.
Tantawy AA; Adly AA; Ismail EA; Habeeb NM; Farouk A
Platelets; 2013; 24(8):605-14. PubMed ID: 23249216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
